Schedule 13G ownership disclosure
Zomedica Pharmaceuticals Corp.
Security class unavailable · CUSIP: 98979F107
Event date: 2017-11-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 42.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001171843-17-007180
- Form type
- SC 13G
- Filer
- Solensky Gerald JR
- CIK
- CIK 1721759
- Filed
- Nov 21, 2017
- Reporting period
- Nov 20, 2017
- Description
- Schedule 13G beneficial ownership